Skip to main content

The Food and Drug Administration’s Accelerated Approval Process for New Pharmaceuticals - A Workshop

Completed

The workshop examined the use of the accelerated approval authority for pharmaceuticals and lessons learned. It examined the current regulatory framework for accelerated approvals and explored ways to strengthen the accelerated approval process. It also examined comparable expedited pathways used by other nations' regulatory health authorities and lessons learned from their experiences.

Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.